These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 31316919

  • 1. Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches.
    Rebello KM, Andrade-Neto VV, Gomes CRB, de Souza MVN, Branquinha MH, Santos ALS, Torres-Santos EC, d'Avila-Levy CM.
    Front Cell Infect Microbiol; 2019; 9():229. PubMed ID: 31316919
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B.
    Valdivieso E, Mejías F, Carrillo E, Sánchez C, Moreno J.
    Int J Antimicrob Agents; 2018 Nov; 52(5):682-687. PubMed ID: 29969693
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG, Mendonça DVC, Tavares GSV, Lage DP, Dias DS, Ribeiro PAF, Perin L, Ludolf F, Coelho VTS, Ferreira ACG, Neves PHAS, Matos GF, Chávez-Fumagalli MA, Coimbra ES, Pereira GR, Coelho EAF, Antinarelli LMR.
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [Abstract] [Full Text] [Related]

  • 4. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
    Reis TAR, Oliveira-da-Silva JA, Tavares GSV, Mendonça DVC, Freitas CS, Costa RR, Lage DP, Martins VT, Machado AS, Ramos FF, Silva AM, Ludolf F, Antinarelli LMR, Brito RCF, Chávez-Fumagalli MA, Humbert MV, Roatt BM, Coimbra ES, Coelho EAF.
    Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
    [Abstract] [Full Text] [Related]

  • 5. Antileishmanial activity of antiretroviral drugs combined with miltefosine.
    Costa S, Machado M, Cavadas C, do Céu Sousa M.
    Parasitol Res; 2016 Oct; 115(10):3881-7. PubMed ID: 27249967
    [Abstract] [Full Text] [Related]

  • 6. Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
    Reimão JQ, Oliveira JC, Trinconi CT, Cotrim PC, Coelho AC, Uliana SR.
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003556. PubMed ID: 25679212
    [Abstract] [Full Text] [Related]

  • 7. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
    Faucher JF, Morquin D, Reynes J, Chirouze C, Hoen B, Le Moing V.
    Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
    [Abstract] [Full Text] [Related]

  • 8. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
    Dos Santos Nogueira F, Avino VC, Galvis-Ovallos F, Pereira-Chioccola VL, Moreira MAB, Romariz APPL, Molla LM, Menz I.
    Parasit Vectors; 2019 Feb 08; 12(1):79. PubMed ID: 30736866
    [Abstract] [Full Text] [Related]

  • 9. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
    Freitas CS, Oliveira-da-Silva JA, Lage DP, Costa RR, Mendonça DVC, Martins VT, Reis TAR, Antinarelli LMR, Machado AS, Tavares GSV, Ramos FF, Coelho VTS, Brito RCF, Ludolf F, Chávez-Fumagalli MA, Roatt BM, Ramos GS, Munkert J, Ottoni FM, Campana PRV, Humbert MV, Coimbra ES, Braga FC, Pádua RM, Coelho EAF.
    Parasitol Res; 2021 Jan 08; 120(1):321-335. PubMed ID: 33191446
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC, de Paula RC, Alves CL, Faria KF, Oliveira MM, Mendes GG, Dias EMFA, Ribeiro RR, Oliveira AB, Silva SMD.
    Exp Parasitol; 2019 Apr 08; 199():67-73. PubMed ID: 30797783
    [Abstract] [Full Text] [Related]

  • 11. Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against Leishmania infantum and Leishmania amazonensis infections.
    Dhorm Pimentel de Moraes AR, Tavares GD, Soares Rocha FJ, de Paula E, Giorgio S.
    Exp Parasitol; 2018 Apr 08; 187():12-21. PubMed ID: 29518448
    [Abstract] [Full Text] [Related]

  • 12. Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.
    Le Fichoux Y, Rousseau D, Ferrua B, Ruette S, Lelièvre A, Grousson D, Kubar J.
    Antimicrob Agents Chemother; 1998 Mar 08; 42(3):654-8. PubMed ID: 9517947
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis.
    Valadares DG, Duarte MC, Ramírez L, Chávez-Fumagalli MA, Martins VT, Costa LE, Lage PS, Ribeiro TG, Castilho RO, Fernandes AP, Régis WC, Soto M, Tavares CA, Coelho EA.
    Exp Parasitol; 2012 Oct 08; 132(2):228-36. PubMed ID: 22824583
    [Abstract] [Full Text] [Related]

  • 14. Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
    Cunha-Júnior EF, Andrade-Neto VV, Lima ML, da Costa-Silva TA, Galisteo Junior AJ, Abengózar MA, Barbas C, Rivas L, Almeida-Amaral EE, Tempone AG, Torres-Santos EC.
    PLoS Negl Trop Dis; 2017 Jan 08; 11(1):e0005281. PubMed ID: 28045892
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
    Mesquita JT, Tempone AG, Reimão JQ.
    Acta Trop; 2014 Feb 08; 130():112-6. PubMed ID: 24239532
    [Abstract] [Full Text] [Related]

  • 16. Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.
    Eberhardt E, Mondelaers A, Hendrickx S, Van den Kerkhof M, Maes L, Caljon G.
    Parasitol Res; 2016 Oct 08; 115(10):4061-70. PubMed ID: 27412759
    [Abstract] [Full Text] [Related]

  • 17. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
    Costa RR, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Mendonça DVC, Freitas CS, Lage DP, Martins VT, Antinarelli LMR, Machado AS, Bandeira RS, Ludolf F, Santos TTO, Brito RCF, Humbert MV, Menezes-Souza D, Duarte MC, Chávez-Fumagalli MA, Roatt BM, Coimbra ES, Coelho EAF.
    Med Microbiol Immunol; 2021 Jun 08; 210(2-3):133-147. PubMed ID: 33870453
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV, Mendonça DVC, Lage DP, Antinarelli LMR, Soyer TG, Senna AJS, Matos GF, Dias DS, Ribeiro PAF, Batista JPT, Poletto JM, Brandão GC, Chávez-Fumagalli MA, Pereira GR, Coimbra ES, Coelho EAF.
    Acta Trop; 2019 Mar 08; 191():29-37. PubMed ID: 30586571
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
    Reimão JQ, Colombo FA, Pereira-Chioccola VL, Tempone AG.
    Exp Parasitol; 2012 Mar 08; 130(3):195-9. PubMed ID: 22281156
    [Abstract] [Full Text] [Related]

  • 20. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M, dos Reis Lage LM, Lage DP, Mesquita JT, Salles BC, Lavorato SN, Menezes-Souza D, Roatt BM, Alves RJ, Tavares CA, Tempone AG, Coelho EA.
    Vet Parasitol; 2016 Feb 15; 217():81-8. PubMed ID: 26827866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.